Back to search

Finland· FI-REL-REL41236

Enurev Breezhaler

A glycopyrronium bromid product containing glycopyrronium bromide, registered in Finland by Novartis Europharm Limited. The same ATC class is registered in 12 of our 19 countries.

ATC R03BB06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedEnurev BreezhalerATCR03BB06REGISTER NO.FI-REL-REL41236PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Glycopyrronium bromid is registered in 12 of 19 countries.

Countries holding a registration under ATC R03BB06 (glycopyrronium bromid), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Glycopyrronium bromid · ATC R03BB06

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glycopyrronium bromid costs, country by country.

Normalised to the WHO defined daily dose (44 mcg), the median price runs from $0.95 in Italy to $1.46 in Switzerland — a ×1.5 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Glycopyrronium bromid · price per daily dose (44 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.46
  • IT Italy$0.95
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Glycopyrronium bromide
Manufacturer
Novartis Europharm Limited
Country
Finland (FI)
ATC code
R03BB06
ATC class
Glycopyrronium bromid
Defined daily dose
44 mcg, Inhal
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

213 interactions on record for glycopyrronium bromid.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glycopyrronium bromid · interactions on record

213 records

  • 6 severe
  • 190 moderate
  • 17 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • TopiramatN02CX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glycopyrronium bromid in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glycopyrronium bromid products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Axhidrox, Glycopyrroniumbromid Accord
  • Belgium · Axhidroks, Robinul
  • Bulgaria · Axhidrox, Амидил Амихалер
  • Cyprus · Glycopyrronium Bromide Accord, Robinul
  • Czechia · Amidil Amihaler, Axhidrox
  • Germany · Axhidrox, Glycopyrronium Axiromed
  • Denmark · Axhidrox, Glycopirronium Medical Valley
  • Estonia · Axhidrox
  • France · Glycopyrronium Biogaran, Glycopyrronium Wolff
  • United Kingdom (Northern Ireland) · Assicco, Glycopyrrolate Mercury Pharmaceuticals
  • Greece · Axhidrox, Glycopyrronium Verisfield
  • Croatia · Axhidrox
  • Hungary · Axhidrox, Rybrila
  • Ireland · Axhidrox, Glycopyrronium Bromide Ethypharm
  • Iceland · Seebri Breezhaler, Sialanar
  • Italy · Axhidrox, Glicopirronio Bromuro Accord
  • Liechtenstein · Seebri Breezhaler, Sialanar
  • Lithuania · Akshidroz
  • Luxembourg · Axhidroks, Robinul
  • Latvia · Axhidrox
  • Malta · Glycopyrronium Morningside
  • Netherlands · Axhidrox, Dusmyla
  • Norway · Axhidrox, Glycopirronium Medical Valley
  • Poland · Amidil Amihaler, Axhidrox
  • Portugal · Glicopirrónio Axidrox
  • Romania · Axhidrox
  • Sweden · Axhidrox, Glycopirronium Medical Valley
  • Slovenia · Axhidrox
  • Slovakia · Axhidrox

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6151e9d9-1d83-426a-a166-bbf3cb6f9d3c
GET /v1/drugs/6151e9d9-1d83-426a-a166-bbf3cb6f9d3c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "44",
  "form": "inhalaatiojauhe, kapseli, kova",
  "route": "Inhalaatioon",
  "ddd_unit": "mcg",
  "strength": "44 mikrog",
  "atc_label": "glykopyrroniumbromidi",
  "ma_number": null,
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": "EU/1/12/789/001-008",
  "fimea_rel_id": "REL41236",
  "authorised_at": "2012-09-28"
}

See everything about glycopyrronium bromid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.